DOCSLIB.ORG

Induction of Regulatory T Cells and Its Regulation with Insulin-Like Growth

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Induction of Regulatory T Cells and Its Regulation with Insulin-Like Growth Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem This information is current as Cells of September 27, 2021. Ippei Miyagawa, Shingo Nakayamada, Kazuhisa Nakano, Kaoru Yamagata, Kei Sakata, Kunihiro Yamaoka and Yoshiya Tanaka J Immunol published online 19 July 2017 Downloaded from http://www.jimmunol.org/content/early/2017/07/19/jimmun ol.1600230 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2017/07/19/jimmunol.160023 Material 0.DCSupplemental Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 27, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published July 19, 2017, doi:10.4049/jimmunol.1600230 The Journal of Immunology Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells Ippei Miyagawa,* Shingo Nakayamada,* Kazuhisa Nakano,* Kaoru Yamagata,* Kei Sakata,*,† Kunihiro Yamaoka,‡ and Yoshiya Tanaka* Human mesenchymal stem cells (MSCs) are multipotent and exert anti-inflammatory effects, but the underlying mechanism re- mains to be elucidated. In the current study, we investigated the regulatory mechanism of regulatory T cell (Treg) induction through the growth factors released by human MSCs. Human naive CD4+ T cells were stimulated with anti-CD3/28 Abs and cocultured with human MSC culture supernatant for 48 h. The proliferation and cytokine production of CD4+ T cells and surface molecule + + expression on CD4 T cells were evaluated. The proliferation of anti-CD3/28 Abs–stimulated CD4 T cells was suppressed by the Downloaded from addition of human MSC culture supernatant; in addition, the production of IL-10 and IL-4 increased. The human MSC culture supernatant induced CD4+FOXP3+ Tregs that expressed CD25, CTLA-4, glucocorticoid-induced TNFR-related protein, insulin- like growth factor (IGF)-1R, and IGF-2R, showing antiproliferative activity against CD4+ T cells. In addition, the induction of Tregs by human MSC culture supernatant was enhanced by the addition of IGF and suppressed by the inhibition of IGF-1R. In contrast, a significant amount of IGF binding protein (IGFBP)-4, an inhibitor of IGF action, was detected in the human MSC culture supernatant. After neutralization of IGFBP-4 in the human MSC culture supernatant by anti–IGFBP-4 Ab, Treg numbers http://www.jimmunol.org/ increased significantly. Thus, our results raise the possibility that human MSC actions also involve a negative-regulatory mech- anism that suppresses Treg proliferation by releasing IGFBP-4. The results of this study suggest that regulation of IGF may be important for treatments using human MSCs. The Journal of Immunology, 2017, 199: 000–000. heumatoid arthritis (RA) is a systemic autoimmune disease chondrocytes, and adipocytes (4, 5). Therefore, they are regarded that is characterized by synovitis and subsequent joint de- as potential therapeutic tools for promoting tissue repair at various R struction (1). Recently developed biological agents, such as sites, including joints. MSCs also have the capacity to modulate TNF-a inhibitors and IL-6R Abs, and JAK inhibitors have proven to immune responses. Studies have shown MSCs to be effective in sup- be more effective than conventional treatments (2, 3); however, some pressing disease progression in animal autoimmune disease models, by guest on September 27, 2021 patients fail to respond to these newer treatments. In addition, no ef- as well as in graft-versus-host disease (GVHD) patients receiving fective treatment for repairing damaged joints has been established. bone marrow transplantation (6–9). However, the mechanism of im- Mesenchymal stem cells (MSCs) are multipotent and exert munosuppression by human MSCs (hMSCs) has not been adequately anti-inflammatory effects. MSCs can differentiate into osteoblasts, explored. We reported previously that hMSCs inhibited osteoclast differ- *First Department of Internal Medicine, University of Occupational and Environ- entiation by producing osteoprotegerin and were able to differentiate mental Health, Kitakyushu 807-8555, Japan; †Mitsubishi Tanabe Pharma, Yokohama, into osteoblasts and chondrocytes under the influence of IL-1 and Kanagawa 227-0033, Japan; and ‡Division of Rheumatology, Department of Internal IL-6 (10–12). We also demonstrated that implantation of hMSCs Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan with a poly-lactic-co-glycolic acid scaffold significantly suppressed ORCID: 0000-0002-8125-8630 (K. Yamagata). arthritis and joint destruction in the collagen-induced arthritis rat Received for publication February 8, 2016. Accepted for publication June 24, 2017. model and reported that their immunomodulatory effect was medi- This work was supported in part by research on rare and intractable diseases and ated by suppression of lymph follicles, splenomegaly, and anti–type Research Grants-in-Aid for Scientific Research by the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technol- II collagen Abs through TGF-b (13). Therefore, we hypothesized ogy of Japan, the Japan Agency for Medical Research and Development, the Uni- that hMSCs might have potential as novel therapeutic tools for tissue versity of Occupational and Environmental Health, Japan, and a University of repairandimmunosuppressioninRApatients. Occupational and Environmental Health Grant for Advanced Research. Regulatory T cells (Tregs) are important for immune tolerance (14– I.M. contributed to the study design, overall review, and writing of the manuscript; the other authors were involved in the performance of the study and review of the 16). TGF-b reportedly plays a role in the mechanism of Treg induc- manuscript; and Y.T. and S.N. participated in the study design and coordination. All tion; however, it is known that MSCs produce growth factors other authors read and approved the final manuscript. than TGF-b (17, 18). In the current study, we found that hMSCs in- Address correspondence and reprint requests to Prof. Yoshiya Tanaka, First Depart- duced Tregs by releasing insulin-like growth factors (IGFs). We also ment of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahata-nishi, Kitakyushu 807-8555, Japan. found that this induction was negatively regulated, in part, by hMSCs E-mail address: [email protected] releasing IGF binding protein (IGFBP)-4, an inhibitor of IGF action. The online version of this article contains supplemental material. Abbreviations used in this article: GITR, glucocorticoid-induced TNFR-related pro- tein; GVHD, graft-versus-host disease; hMSC, human MSC; IGF, insulin-like growth Materials and Methods factor; IGFBP, IGF binding protein; IGFR, IGF receptor; MSC, mesenchymal stem Preparation of hMSCs cell; RA, rheumatoid arthritis; Treg, regulatory T cell. Bone marrow–derived hMSCs were cultured with MSCGM Mesenchymal Copyright Ó 2017 by The American Association of Immunologists, Inc. 0022-1767/17/$30.00 Stem Cell Growth Bulletkit Medium (both from Lonza, Walkersville, MD) www.jimmunol.org/cgi/doi/10.4049/jimmunol.1600230 2 INDUCTION OF Tregs WITH IGF/IGFBP-4 + 5 in culture flasks at 37˚C under 5% CO2 atmosphere. They were used in Ab-stimulated CFSE-labeled human CD4 T cells (2 3 10 cells) for 96 h experiments after 75–85% confluence after one or two passages expanding (1:10). The proliferation of CD4+ T cells was evaluated using a CFSE within 3–7 d. Ethylene diamine tetraacetic acid 0.01%/trypsin was used to dilution assay. Levels of IL-10 in the culture supernatant were determined release the cells from the culture flasks. hMSCs were seeded directly onto using a BD Cytometric Bead Array (CBA) Human Flex Set, according to 12-well plastic plates at a density of 4 3 104 cells per well and cultured in the manufacturer’s instructions (BD Pharmingen). In addition, the con- 1000 ml of RPMI 1640 (Wako Pure Clinical Industries, Osaka, Japan) centration of soluble CD25 was measured by ELISA as a surrogate marker supplemented with 10% FCS (Tissue Culture Biologicals, Tulare, CA), of T cell activation (IL-2Ra, soluble, human, ELISA Kit, Quantikine, 100 U/ml penicillin, and 100 U/ml streptomycin (Invitrogen, New York, RSD). In addition, CFSE-labeled CD4+CD25+ T cells (CD4+FOXP3+ NY). After 4 d of culture, hMSC supernatant was collected for later use. T cells) were cocultured with plate-bound anti-CD3 (2 mg/ml) and soluble CD28 (1 mg/ml) Ab-stimulated human CD4+ T cells (2 3 105 cells) for + CD4 T cell isolation and culture conditions 96 h (1:10) to evaluate the proliferation of Tregs during coculture. The proliferation of CD4+CD25+
Load more

Recommended publications
  • Endothelial Cells and the IGF System
    L A Bach Endothelial cells as IGF targets 54:1 R1–R13 Review Endothelial cells and the IGF system Correspondence 1,2 Leon A Bach should be addressed to L A Bach 1Department of Medicine (Alfred), Monash University, Prahran 3181, Australia Email 2Department of Endocrinology and Diabetes, Alfred Hospital, Commercial Road, Melbourne 3004, Australia [email protected] Abstract Endothelial cells line blood vessels and modulate vascular tone, thrombosis, inflammatory Key Words responses and new vessel formation. They are implicated in many disease processes including " insulin-like growth factor atherosclerosis and cancer. IGFs play a significant role in the physiology of endothelial cells " binding protein by promoting migration, tube formation and production of the vasodilator nitric oxide. " receptor These actions are mediated by the IGF1 and IGF2/mannose 6-phosphate receptors and are " endothelial cell modulated by a family of high-affinity IGF binding proteins. IGFs also increase the number " angiogenesis and function of endothelial progenitor cells, which may contribute to protection from atherosclerosis. IGFs promote angiogenesis, and dysregulation of the IGF system may contribute to this process in cancer and eye diseases including retinopathy of prematurity and diabetic retinopathy. In some situations, IGF deficiency appears to contribute to endothelial dysfunction, whereas IGF may be deleterious in others. These differences may be due to tissue-specific endothelial cell phenotypes or IGFs having distinct roles in different phases of vascular disease. Further studies are therefore required to delineate the Journal of Molecular therapeutic potential of IGF system modulation in pathogenic processes. Endocrinology (2015) 54, R1–R13 Journal of Molecular Endocrinology Introduction Insulin-like growth factor 1 (IGF1) and IGF2 are essential metabolically active and regulate vascular tone, thrombosis, for normal pre- and postnatal growth and development inflammatory responses and new vessel formation.
    [Show full text]
  • Insulin-Like Growth Factor Axis in Pregnancies Affected by Fetal Growth Disorders Aamod R
    Nawathe et al. Clinical Epigenetics (2016) 8:11 DOI 10.1186/s13148-016-0178-5 RESEARCH Open Access Insulin-like growth factor axis in pregnancies affected by fetal growth disorders Aamod R. Nawathe1,2, Mark Christian3, Sung Hye Kim2, Mark Johnson1,2, Makrina D. Savvidou1,2 and Vasso Terzidou1,2* Abstract Background: Insulin-like growth factors 1 and 2 (IGF1 and IGF2) and their binding proteins (IGFBPs) are expressed in the placenta and known to regulate fetal growth. DNA methylation is an epigenetic mechanism which involves addition of methyl group to a cytosine base in the DNA forming a methylated cytosine-phosphate-guanine (CpG) dinucleotide which is known to silence gene expression. This silences gene expression, potentially altering the expression of IGFs and their binding proteins. This study investigates the relationship between DNA methylation of components of the IGF axis in the placenta and disorders in fetal growth. Placental samples were obtained from cord insertions immediately after delivery from appropriate, small (defined as birthweight <10th percentile for the gestation [SGA]) and macrosomic (defined as birthweight > the 90th percentile for the gestation [LGA]) neonates. Placental DNA methylation, mRNA expression and protein levels of components of the IGF axis were determined by pyrosequencing, rtPCR and Western blotting. Results: In the placenta from small for gestational age (SGA) neonates (n = 16), mRNA and protein levels of IGF1 were lower and of IGFBPs (1, 2, 3, 4 and 7) were higher (p < 0.05) compared to appropriately grown neonates (n =37).In contrast, in the placenta from large for gestational age (LGA) neonates (n = 20), mRNA and protein levels of IGF1 was not different and those of IGFBPs (1, 2, 3 and 4) were lower (p < 0.05) compared to appropriately grown neonates.
    [Show full text]
  • Supplementary Table 1: Genes Affected by Anoikis. A, Ratio of Signal
    Supplementary Table 1: Genes affected by anoikis. a, ratio of signal intensity of nonanchored cells anchorage dependent cells (CasKoSrc) over anchored cells; b, induced by Src transformation of Cx43KO cells; c, decreased by Src transformation of Cx43Ko cells; *, induced by normalization of Src transformed cells by neighboring nontransformed cells. Gene Symbol Probe Set Fold Changea Gene Name increased Selenbp1 1450699_at 23.22 selenium binding protein 1 Dscr1l1 1450243_a_at 10.77 Down syndrome critical region gene 1-like 1 Dscr1l1 1421425_a_at 4.29 Down syndrome critical region gene 1-like 1 Ttyh1 1426617_a_at 6.70 tweety homolog 1 (Drosophila) 5730521E12Rik 1419065_at 6.16 RIKEN cDNA 5730521E12 gene c 6330406I15Rik 1452244_at 5.87 RIKEN cDNA 6330406I15 gene AF067063 1425160_at 5.73 clone L2 uniform group of 2-cell-stage gene family mRNA Morc 1419418_a_at 5.55 microrchidia c Gpr56 1421118_a_at 5.43 G protein-coupled receptor 56 Pax6 1452526_a_at 5.06 paired box gene 6 Tgfbi 1415871_at 3.73 transforming growth factor beta induced Adarb1 1434932_at 3.70 adenosine deaminase RNA-specific B1 Ddx3y 1452077_at 3.30 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked b Ampd3 1422573_at 3.20 AMP deaminase 3 Gli2 1459211_at 3.07 GLI-Kruppel family member GLI2 Selenbp2 1417580_s_at 2.96 selenium binding protein 2 Adamts1 1450716_at 2.80 a disintegrin-like and metalloprotease with thrombospondin type 1 motif 1 Dusp15 1426189_at 2.70 dual specificity phosphatase-like 15 Dpep3 1429035_at 2.60 dipeptidase 3 Sepp1 1452141_a_at 2.57 selenoprotein P plasma
    [Show full text]
  • Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
    Supplementary Online Content Ganz P, Heidecker B, Hveem K, et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA. doi: 10.1001/jama.2016.5951 eTable 1. List of 1130 Proteins Measured by Somalogic’s Modified Aptamer-Based Proteomic Assay eTable 2. Coefficients for Weibull Recalibration Model Applied to 9-Protein Model eFigure 1. Median Protein Levels in Derivation and Validation Cohort eTable 3. Coefficients for the Recalibration Model Applied to Refit Framingham eFigure 2. Calibration Plots for the Refit Framingham Model eTable 4. List of 200 Proteins Associated With the Risk of MI, Stroke, Heart Failure, and Death eFigure 3. Hazard Ratios of Lasso Selected Proteins for Primary End Point of MI, Stroke, Heart Failure, and Death eFigure 4. 9-Protein Prognostic Model Hazard Ratios Adjusted for Framingham Variables eFigure 5. 9-Protein Risk Scores by Event Type This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Supplemental Material Table of Contents 1 Study Design and Data Processing ......................................................................................................... 3 2 Table of 1130 Proteins Measured .......................................................................................................... 4 3 Variable Selection and Statistical Modeling ........................................................................................
    [Show full text]
  • Trim24-Regulated Estrogen Response Is Dependent on Specific Histone Modifications in Breast Cancer Cells
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2012 TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE MODIFICATIONS IN BREAST CANCER CELLS Teresa T. Yiu Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biochemistry Commons, Cancer Biology Commons, Medicine and Health Sciences Commons, and the Molecular Biology Commons Recommended Citation Yiu, Teresa T., "TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE MODIFICATIONS IN BREAST CANCER CELLS" (2012). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 313. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/313 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE
    [Show full text]
  • Insulin-Like Growth Factor Binding Proteins 4 and 7 Released by Senescent Cells Promote Premature Senescence in Mesenchymal Stem Cells
    Citation: Cell Death and Disease (2013) 4, e911; doi:10.1038/cddis.2013.445 OPEN & 2013 Macmillan Publishers Limited All rights reserved 2041-4889/13 www.nature.com/cddis Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells V Severino1,2,3,10, N Alessio4,10, A Farina5, A Sandomenico2,3, M Cipollaro4, G Peluso6,7, U Galderisi*,4,6,8,9 and A Chambery*,1,3 Cellular senescence is the permanent arrest of cell cycle, physiologically related to aging and aging-associated diseases. Senescence is also recognized as a mechanism for limiting the regenerative potential of stem cells and to protect cells from cancer development. The senescence program is realized through autocrine/paracrine pathways based on the activation of a peculiar senescence-associated secretory phenotype (SASP). We show here that conditioned media (CM) of senescent mesenchymal stem cells (MSCs) contain a set of secreted factors that are able to induce a full senescence response in young cells. To delineate a hallmark of stem cells SASP, we have characterized the factors secreted by senescent MSC identifying insulin-like growth factor binding proteins 4 and 7 (IGFBP4 and IGFBP7) as key components needed for triggering senescence in young MSC. The pro-senescent effects of IGFBP4 and IGFBP7 are reversed by single or simultaneous immunodepletion of either proteins from senescent-CM. The blocking of IGFBP4/7 also reduces apoptosis and promotes cell growth, suggesting that they may have a pleiotropic effect on MSC biology. Furthermore, the simultaneous addition of rIGFBP4/7 increased senescence and induced apoptosis in young MSC.
    [Show full text]
  • IGFBP4 Antibody
    Product Datasheet IGFBP4 antibody Catalog No: #38333 Orders: [email protected] Description Support: [email protected] Product Name IGFBP4 antibody Host Species Rabbit Clonality Polyclonal Purification Antibodies were purified by affinity purification using immunogen. Applications WB,IHC,IF Species Reactivity Human,Mouse,Rat Specificity The antibody detects endogenous level of total IGFBP4 antibody. Immunogen Type Recombinant Protein Immunogen Description Recombinant protein of human IGFBP4. Target Name IGFBP4 Other Names BP-4; IBP4; IGFBP-4; HT29-IGFBP; Accession No. Swiss-Prot#: P22692NCBI Gene ID: 3487 SDS-PAGE MW 28kd Concentration 1.0mg/ml Formulation Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Storage Store at -20°C Application Details WB 1:500 - 1:2000IHC 1:50 - 1:100IF 1:50 - 1:200 Images Immunofluorescence analysis of L929 cells using IGFBP4 at dilution of 1:100. Blue: DAPI for nuclear staining. Address: 8400 Baltimore Ave., Suite 302, College Park, MD 20740, USA http://www.sabbiotech.com 1 Immunohistochemistry of paraffin-embedded rat brain using IGFBP4 at dilution of 1:100 (40x lens). Immunohistochemistry of paraffin-embedded human stomach using IGFBP4 at dilution of 1:100 (40x lens). Western blot analysis of extracts of various cell lines, using IGFBP4 at 1:1000 dilution. Immunohistochemistry of paraffin-embedded mouse brain using IGFBP4 at dilution of 1:100 (40x lens). Background This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain.
    [Show full text]
  • Intermittent High Glucose Concentrations Reduce Neuronal Precursor
    523 Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1) S Giannini1, S Benvenuti2, P Luciani2, C Manuelli3, I Cellai2, C Deledda2, A Pezzatini1, G B Vannelli4, E Maneschi2, C M Rotella1, M Serio2 and A Peri2 1Diabetes and Metabolic Diseases Unit and 2Endocrine Unit, Department of Clinical Physiopathology, Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies (DENOThe), 3Institute of Dermatology and Venereology and 4Department of Anatomy, Histology and Forensic Medicine, University of Florence, Viale Pieraccini, 6, 50139 Florence, Italy (Correspondence should be addressed to A Peri; Email: [email protected]fi.it) Abstract The exposure of neurons to high glucose concentrations is (now known as DHCR24 ), which acts as a pro-survival factor considered a determinant of diabetic neuropathy, whereas for neuronal cells. Conversely, the exposure to intermittent members of the IGF system are neurotropic factors. Here, we (20/10 mM), but not stable (20 mM), high glucose concen- investigated the effects of constant and intermittent high glucose trations decreased the release of IGF1 and IGFBP2 in the culture concentrations on IGF1 and IGF-binding proteins (IGFBPs) in medium and inhibited FNC growth by inducing apoptosis. The human neuroblast long-term cell cultures fetal neuroepithelial latter was prevented by the addition of IGF1 to the culture cells (FNC). These cells express the IGF1 receptor, and express medium. Furthermore, high glucose concentrations reduced and release in the culture medium IGFBP2, IGFBP4, and IGF1. the expression of DHCR24.
    [Show full text]
  • Chromatin Reader Dido3 Regulates the Genetic Network of B Cell Differentiation
    bioRxiv preprint doi: https://doi.org/10.1101/2021.02.23.432411; this version posted March 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Chromatin reader Dido3 regulates the genetic network of B cell differentiation Fernando Gutiérrez del Burgo1, Tirso Pons1, Enrique Vázquez de Luis2, Carlos Martínez-A1 & Ricardo Villares1,* 1 Centro Nacional de Biotecnología/CSIC, Darwin 3, Cantoblanco, E‐28049, Madrid, Spain 2 Centro Nacional de Investigaciones Cardiovasculares, Instituto de Salud Carlos III, Melchor Fernández Almagro 3, Madrid 28029, Spain. *email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.02.23.432411; this version posted March 12, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT The development of hematopoietic lineages is based on a complex balance of transcription factors whose expression depends on the epigenetic signatures that characterize each differentiation step. The B cell lineage arises from hematopoietic stem cells through the stepwise silencing of stemness genes and balanced expression of mutually regulated transcription factors, as well as DNA rearrangement. Here we report the impact on B cell differentiation of the lack of DIDO3, a reader of chromatin status, in the mouse hematopoietic compartment.
    [Show full text]
  • Mutation of IGFBP7 Causes Upregulation of BRAF/MEK/ERK Pathway and Familial Retinal Arterial Macroaneurysms
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REPORT Mutation of IGFBP7 Causes Upregulation of BRAF/MEK/ERK Pathway and Familial Retinal Arterial Macroaneurysms Leen Abu-Safieh,1,10 Emad B. Abboud,2,10 Hisham Alkuraya,1,2,10 Hanan Shamseldin,1 Shamsa Al-Enzi,1 Lama Al-Abdi,1 Mais Hashem,1 Dilek Colak,3 Abdullah Jarallah,4 Hala Ahmad,5 Steve Bobis,5 Georges Nemer,6 Fadi Bitar,7 and Fowzan S. Alkuraya1,8,9,* Insulin-like growth factor binding proteins (IGFBPs) play important physiological functions through the modulation of IGF signaling as well as IGF-independent mechanisms. Despite the established role of IGFs in development, a similar role for the seven known IGFBPs has not been established in humans. Here, we show that an autosomal-recessive syndrome that consists of progressive retinal arterial macro- aneurysms and supravalvular pulmonic stenosis is caused by mutation of IGFBP7. Consistent with the recently established inhibitory role of IGFBP7 on BRAF signaling, the BRAF/MEK/ERK pathway is upregulated in these patients, which may explain why the cardiac phenotype overlaps with other disorders characterized by germline mutations in this pathway. The retinal phenotype appears to be mediated by a role in vascular endothelium, where IGFBP7 is highly expressed. Insulin-like growth factors IGF1 (MIM 147440) and IGF2 type in mice in which individual Igfbps have been knocked (MIM 147470) are signaling polypeptides that are involved out.5,7 Therefore, study of IGFBPs
    [Show full text]
  • The Role of Insulin-Like Growth Factor Binding Protein 2 (IGFBP2) in the Regulation of Corneal Fibroblast Differentiation
    Cornea The Role of Insulin-Like Growth Factor Binding Protein 2 (IGFBP2) in the Regulation of Corneal Fibroblast Differentiation Soo Hyun Park, Kyoung Woo Kim, and Jae Chan Kim Department of Ophthalmology, College of Medicine, Chung-Ang University Hospital, Seoul, Korea Correspondence: Jae Chan Kim, De- PURPOSE. Previously, we reported that keratocyte-conditioned medium (KCM) facilitates the partment of Ophthalmology, Chung- differentiation of human mesenchymal stem cells (hMSCs) into corneal keratocyte–like cells. Ang University Hospital, 224-1, This study is designed to investigate the roles of insulin-like growth factor binding protein 2 Heukseok-dong, Dongjak-gu, Seoul (IGFBP2) for the regulation of corneal fibroblast differentiation as a newly unveiled 156-755, Korea; component of KCM. [email protected]. Submitted: February 4, 2015 METHODS. Immunodot blot analysis was performed to identify the factors that are highly Accepted: October 5, 2015 secreted, especially in KCM. Then, we investigated whether IGFBP2 differentiates hMSCs into keratocyte-like cells and whether maintains the phenotypes of keratocyte in human corneal Citation: Park SH, Kim KW, Kim JC. fibroblasts (HCFs) by analyzing expression patterns of alpha-smooth muscle actin (a-SMA) and The role of insulin-like growth factor binding protein 2 (IGFBP2) in the keratocyte markers including keratocan, lumican and aldehyde dehydrogenase 1 family regulation of corneal fibroblast differ- member A1 (ALDH1A1). Furthermore, to specify the role of IGFBP2, the expression of a-SMA entiation. Invest Ophthalmol Vis Sci. and keratocyte markers was determined in transforming growth factor b 1 (TGFb1)-induced 2015;56:7293–7302. DOI:10.1167/ corneal myofibroblast and in HCFs after knockdown of IGFBP2.
    [Show full text]
  • Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands That Promote Axonal Growth
    Research Article: New Research Development Peripheral Nerve Single-Cell Analysis Identifies Mesenchymal Ligands that Promote Axonal Growth Jeremy S. Toma,1 Konstantina Karamboulas,1,ª Matthew J. Carr,1,2,ª Adelaida Kolaj,1,3 Scott A. Yuzwa,1 Neemat Mahmud,1,3 Mekayla A. Storer,1 David R. Kaplan,1,2,4 and Freda D. Miller1,2,3,4 https://doi.org/10.1523/ENEURO.0066-20.2020 1Program in Neurosciences and Mental Health, Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada, 2Institute of Medical Sciences University of Toronto, Toronto, Ontario M5G 1A8, Canada, 3Department of Physiology, University of Toronto, Toronto, Ontario M5G 1A8, Canada, and 4Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5G 1A8, Canada Abstract Peripheral nerves provide a supportive growth environment for developing and regenerating axons and are es- sential for maintenance and repair of many non-neural tissues. This capacity has largely been ascribed to paracrine factors secreted by nerve-resident Schwann cells. Here, we used single-cell transcriptional profiling to identify ligands made by different injured rodent nerve cell types and have combined this with cell-surface mass spectrometry to computationally model potential paracrine interactions with peripheral neurons. These analyses show that peripheral nerves make many ligands predicted to act on peripheral and CNS neurons, in- cluding known and previously uncharacterized ligands. While Schwann cells are an important ligand source within injured nerves, more than half of the predicted ligands are made by nerve-resident mesenchymal cells, including the endoneurial cells most closely associated with peripheral axons. At least three of these mesen- chymal ligands, ANGPT1, CCL11, and VEGFC, promote growth when locally applied on sympathetic axons.
    [Show full text]